EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stage-specific biomarkers in triple-negative breast cancer: Preliminary findings from bioinformatics approaches

Faeze Shahraki, Azadeh Meshkini iD, Elham Nazari

Cancer Biomarkers · 2026-05 · 43

DOI: 10.1177/18758592261454886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 28.05.2026. Verfasst von Faeze Shahraki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Computational Biology, Biomarkers, Tumor. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ferdowsi University of Mashhad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Integrated bioinformatics approaches were used to identify stage-specific candidate genes and potential drug targets in triple-negative breast cancer (TNBC).

Methods

Microarray (164 early-stage, 33 advanced-stage, and 53 normal samples) and RNA-seq (113 normal, 163 early-stage, and 30 advanced-stage TNBC samples) datasets were analyzed. Differentially expressed genes (DEGs) were identified, followed by co-expression analysis using Weighted Gene Co-expression Network Analysis (WGCNA) and protein–protein interaction analysis using the STRING database. miRNA co-regulation was evaluated using multiMiR and TCGA correlation analyses. Candidate genes were validated using UALCAN and immunohistochemistry data. Molecular docking assessed potential therapeutic agents.

Results

Novel stage-specific candidate biomarkers were identified, including DNAJC6 , SKP2 , MOCOS , and NCAPD2 in early-stage TNBC, and F11R , FOXO6 , PPP4C , and TMEM51 in advanced-stage TNBC. UALCAN analysis confirmed the dysregulation of these genes across 23 additional malignancies. STRING-based network analysis revealed stage-specific protein–protein interactions, including SKP2–SKP1 in early-stage and F11R–TJP1 in advanced-stage TNBC. miRNA co-regulation distinguished early-stage TNBC through PI3K–AKT–related pathways and advanced-stage TNBC through tumor progression–associated pathways. Docking-based drug repurposing highlighted conventional agents (e.g., doxorubicin) and potential novel candidates (e.g., sunitinib).

Conclusion

This study identifies novel stage-specific gene candidates and suggests repurposable drugs for TNBC, supporting progression-specific targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsComputational BiologyBiomarkers, TumorHumansFemaleGene Expression Regulation, NeoplasticNeoplasm StagingGene Expression ProfilingProtein Interaction MapsMicroRNAsGene Regulatory NetworksMolecular Docking Simulation

Stichwörter der Autor:innen

Triple-Negative breast cancer (TNBC)bioinformaticscancer stagingdrug repurposingmicroarray gene expression profiles

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran.
  • Department of Health Information Technology and Management, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Azadeh Meshkini

Förderung

  • Ferdowsi University of Mashhad

Zitieren

APA

Shahraki, F., Meshkini, A., & Nazari, E. (2026). Stage-specific biomarkers in triple-negative breast cancer: Preliminary findings from bioinformatics approaches. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261454886

Vancouver

Shahraki F, Meshkini A, Nazari E. Stage-specific biomarkers in triple-negative breast cancer: Preliminary findings from bioinformatics approaches. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261454886

BibTeX
@article{Shahraki2026,
  author = {Shahraki, Faeze and Meshkini, Azadeh and Nazari, Elham},
  title = {Stage-specific biomarkers in triple-negative breast cancer: Preliminary findings from bioinformatics approaches},
  journal = {Cancer Biomarkers},
  year = {2026},
  volume = {43},
  doi = {10.1177/18758592261454886}
}
Kostenlos starten →